Comments

Merus Stock Price, Quotes and Forecasts

Q: What sector and industry does Merus (MRUS) operate in?

Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

MRUSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$40.90

-1.87-4.37%

At close: -

$41.38

0.481.17%

After Hours: May 9, 6:36 PM EDT

Q1 2025 Earnings were released on Wed May 7th, after the market close

Merus (MRUS) Forecast

News Earnings Merus (MRUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Merus Stock Price, Quotes and Forecasts | NASDAQ:MRUS | Benzinga

Explore Merus stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MRUS.

Open	$43.00
Close	$40.90
Volume / Avg.	556.50K / 762.18K
Day Range	$40.90 - $44.22
52 Wk Range	33.19 - 61.61
Market Cap	$2.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	8.56%
Days to Cover	8.8

Recent News

Merus Shares Are Up Today: What's Going On?

Shares of Merus N.V. (NASDAQ: MRUS) are trading higher Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for petosemtamab in combination with pembrolizumab.

Vaishali Prayag

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

What's Going On With Merus Stock Monday?

Merus announced a research collaboration and license agreement with Biohaven.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$43.00
Close	$40.90
Volume / Avg.	556.50K / 762.18K
Day Range	$40.90 - $44.22
52 Wk Range	33.19 - 61.61
Market Cap	$2.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	8.56%
Days to Cover	8.8

About

Sector

Healthcare

Industry

N/A

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. ...

Got Questions? Ask

How is MRUS's price-to-book ratio?

What is MRUS's 7 days volume trend?

What is MRUS's current ratio?

What is the consensus rating for MRUS?

What’s the latest news on MRUS?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Merus (MRUS) stock?

You can purchase shares of Merus (NASDAQ:MRUS) through any online brokerage.

View our list of the best stock brokerages

Who are Merus (MRUS) competitors?

There are no as such competitors for Merus.

What is the forecast, or price target, for Merus (MRUS) stock?

Merus has a consensus price target of $75.21.

What is the current price for Merus (MRUS)?

The stock price for Merus (NASDAQ: MRUS) is $41.38 last updated May 9, 2025 at 6:36 PM EDT.

Does Merus (MRUS) pay a dividend?

There are no upcoming dividends for Merus.

When is Merus (NASDAQ:MRUS) reporting earnings?

Merus’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Merus (MRUS) going to split?

There is no upcoming split for Merus.

What sector and industry does Merus (MRUS) operate in?

Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.